Skip to content

the effect of Laxi herb® on constipation in pregnant women

Comparing the effect of Laxi herb® syrup (containing plum and brown sugar) with magnesium hydroxide syrup on constipation in pregnant women: A phase IV randomized double-blind controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190527043729N3
Enrollment
70
Registered
2026-01-26
Start date
2026-02-20
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation. Constipation

Interventions

Intervention 1: Intervention group: Participants in this group will receive LaxiHerb syrup produced by Barij Essence Pharmaceutical Company. This syrup contains plum extract and brown sugar. The dosag

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Healthy pregnant women with constipation who meet at least two of the six diagnostic criteria according to the Rome IV classification No use of medications for constipation during the week prior to the initiation of the intervention Gestational age is 14 weeks or more Presence of a singleton pregnancy Normal fetal growth and development according to gestational age Participant must be Iranian and a resident of Behbahan Be literate in reading and writing

Exclusion criteria

Exclusion criteria: Any severe maternal pregnancy complications Abnormal bowel movements caused by organic or endocrine diseases Use of any drugs with side effects of diarrhea or constipation during the week preceding the intervention. Severe cardiovascular, hepatic, pulmonary, renal, or other major organ diseases Presence of major gastrointestinal diseases, including active peptic or intestinal ulcers, inflammatory bowel disease, severe anorectal disorders, Hirschsprung's disease, or intestinal obstruction Previous gastrointestinal surgical procedures Spinal abnormalities Any metabolic disease, including hypothyroidism and diabetes mellitus History of neurological diseases, including epilepsy, stroke, etc., based on patient report

Design outcomes

Primary

MeasureTime frame
Intensity of constipation. Timepoint: At the beginning of the intervention and 4 weeks after the intervention. Method of measurement: ROME IV Diagnostic Questionnaire for Functional Constipation in Adults.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Ghanbaryan

Tehran University of Medical Sciences

lghanbaryan@yahoo.com+98 21 8897 4535

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026